Pharmicell Working Capital to Net Assets Ratio
Pharmicell working capital to net assets ratio. Pharmicell (005690) has a Working Capital to Net Assets ratio of 63.4% as of September 2025. Working capital of ₩70.03 Billion (current assets of ₩77.16 Billion minus current liabilities of ₩7.13 Billion) is measured against net assets of ₩110.43 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Pharmicell to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pharmicell (2010–2024)
Working capital to net assets ratio of Pharmicell from 2010 to 2024. This chart shows how Pharmicell's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2010 to 2024. As of September 2025, the ratio stands at 63.4%, reflecting working capital of ₩70.03 Billion against net assets of ₩110.43 Billion KRW. See defensive interval ratio of Pharmicell to measure how many days the company can operate on defensive assets alone.
Pharmicell Working Capital to Net Assets Ratio by Year (2010–2024)
Pharmicell working capital to net assets ratio by year from 2010 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Pharmicell from 2010 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 005690 total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 46.7% | ₩40.39 Billion | ₩86.44 Billion | ₩48.04 Billion | ₩7.65 Billion | ▲ +2.7 pp |
| 2023 | 44.0% | ₩35.40 Billion | ₩80.40 Billion | ₩43.17 Billion | ₩7.76 Billion | ▼ -0.1 pp |
| 2022 | 44.1% | ₩33.82 Billion | ₩76.66 Billion | ₩62.36 Billion | ₩28.55 Billion | ▼ -18.7 pp |
| 2021 | 62.8% | ₩40.10 Billion | ₩63.87 Billion | ₩65.04 Billion | ₩24.94 Billion | ▼ -1.0 pp |
| 2020 | 63.8% | ₩36.43 Billion | ₩57.11 Billion | ₩42.94 Billion | ₩6.51 Billion | ▲ +7.3 pp |
| 2019 | 56.5% | ₩29.13 Billion | ₩51.52 Billion | ₩34.65 Billion | ₩5.53 Billion | ▼ -5.0 pp |
| 2018 | 61.5% | ₩29.21 Billion | ₩47.49 Billion | ₩32.53 Billion | ₩3.32 Billion | ▲ +19.6 pp |
| 2017 | 41.9% | ₩23.47 Billion | ₩55.99 Billion | ₩25.85 Billion | ₩2.38 Billion | ▲ +11.6 pp |
| 2016 | 30.3% | ₩28.71 Billion | ₩94.60 Billion | ₩30.53 Billion | ₩1.82 Billion | ▲ +29.0 pp |
| 2013 | 1.3% | ₩1.09 Billion | ₩82.42 Billion | ₩13.92 Billion | ₩12.83 Billion | ▼ -1.0 pp |
| 2012 | 2.3% | ₩2.32 Billion | ₩101.58 Billion | ₩33.50 Billion | ₩31.18 Billion | ▲ +4.0 pp |
| 2011 | -1.8% | ₩-1.45 Billion | ₩82.82 Billion | ₩15.03 Billion | ₩16.48 Billion | ▲ +27.3 pp |
| 2010 | -29.1% | ₩-2.88 Billion | ₩9.90 Billion | ₩16.29 Billion | ₩19.17 Billion | — |